Repligen reported $555K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agilent A:US USD 3M 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bristol Myers Squibb BMY:US USD 292M 0
Bruker BRKR:US USD 1.7M 0
Catalent CTLT:US USD 2M 0
Charles River Laboratories CRL:US USD 510K 0
Danaher DHR:US USD 9M 0
Dentsply International XRAY:US USD 3M 0
Exact Sciences EXAS:US USD 1.77M 5K
Fluidigm FLDM:US USD 79K 0
General Electric GE:US USD 15M 0
Henry Schein HSIC:US USD 1000K 0
Illumina ILMN:US USD 2M 0
IQVIA Holdings Inc IQV:US USD 2.56M 437K
Mettler Toledo International MTD:US USD 448K 0
Myriad Genetics MYGN:US USD 800K 0
Nanostring Technologies NSTG:US USD 5K 0
Orasure Technologies OSUR:US USD 0 0
Pacific Biosciences Of California PACB:US USD 226K 1000
Patterson Companies PDCO:US USD 970K 1000
Peregrine Pharmaceuticals PPHM:US USD 62K 0
Repligen RGEN:US USD 555K 0
West Pharmaceutical Services WST:US USD 18.8M 0